|
KMID : 0606920110190020218
|
|
Biomolecules & Therapeutics
2011 Volume.19 No. 2 p.218 ~ p.223
|
|
|
Spinach Saponin-Enriched Fraction Inhibits Platelet Aggregation in cAMP- and cGMP-Dependent Manner by Decreasing TXA2 Production and Blood Coagulation
|
|
Cho Hyun-Jeong
Choi Sun-A
Kim Chun-Gyu
Jung Tae-Sung
Hong Jeong-Hwa
Rhee Man-Hee
Park Hye-Jin
Park Hwa-Jin
|
|
|
Abstract
|
|
|
|
In this study, we investigated the effect of spinach saponin-enriched fraction (SSEF) on collagen (10 μg/ml)-stimulated platelet aggregation. SSEF inhibited collagen-induced platelet aggregation, and which was involved in the inhibition of thromboxane A2 (TXA2) production, an intracellular Ca2+-agonist as an aggregation-inducing autacoidal molecule. In addition, SSEF signifi cantly increased the formation of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), intracellular Ca2+-antagonists as aggregation-inhibiting molecules, in collagen-stimulated platelets. These results suggest that SSEF might inhibit Ca2+-elevation and TXA2 formation by increasing the production of Ca2+-antagonistic molecules cAMP and cGMP. These mean that SSEF is a potent inhibitor of collagen-stimulated platelet aggregation. On the other hand, prothrombin time (PT) and activated partial thromboplastin time (APTT) were potently prolonged by SSEF. These fi ndings suggest that SSEF prolongs the internal time between the conversion of fi brinogen to fi brin. Accordingly, our data demonstrate that SSEF may be a crucial tool for a negative regulator during platelet activation and blood coagulation on thrombotic diseases.
|
|
|
KEYWORD
|
|
|
Spinach saponin-enriched fraction (SSEF), Platelet aggregation, Blood coagulation, Thrombotic diseases
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|